- TWD15.68bn
- TWD11.18bn
- -TWD2.23bn
Annual balance sheet for Diamond Biofund, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 6,667 | 10,087 | 10,738 | 9,647 | 5,130 |
| Net Total Receivables | 1.98 | 1.69 | 1.86 | 1.12 | 7.74 |
| Total Other Current Assets | |||||
| Total Current Assets | 6,669 | 10,089 | 10,741 | 9,656 | 5,140 |
| Net Property, Plant And Equipment | 55.6 | 43.9 | 5.7 | 125 | 135 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 9,257 | 10,623 | 11,194 | 13,042 | 10,675 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 114 | 198 | 144 | 66 | 208 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 157 | 231 | 144 | 180 | 302 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 9,100 | 10,392 | 11,050 | 12,862 | 10,373 |
| Total Liabilities & Shareholders' Equity | 9,257 | 10,623 | 11,194 | 13,042 | 10,675 |
| Total Common Shares Outstanding |